Vaccine development and effectiveness

In their Washington Post op-ed, The FDA was wrong to delay vaccines for kids under 5, Govid Persad, Alyssa Burgart, and Emily Largent suggest the FDA should have authorized COVID-19 vaccines for children under the age of 5. February 2022

COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales, by Stuart Bedston et al., explores vaccine effectiveness and protection for health care workers at higher risk of SARS-CoV-2 exposure than the general population. In press, January 2022

Coronavirus Variants and Mutations by Jonathan Corum and Carl Zimmer, an updated archive of recent information, March 22, 2021
How do coronavirus variants form and will the current vaccines work against them? Pitt faculty Ghady Haidar and Paul Duprex appeared on 60 Minutes on March 14, 2021, to explain their study (published in Science) of mutations in the coronavirus; also appearing are David Ho and Francis Collins discussing emerging variants and vaccine effectiveness
How Herd Immunity Works — And What Stands In Its Way, a simulation from NPR, February 18, 2021

Vaccine Update: Development, Approval, Allocation and Distribution in the US, an archived webinar presented by the National Academy of Medicine and the American Public Health Association, first presented November 18, 2020

Walid Gellad, Director of Pitt’s Center for Pharmaceutical Policy and Prescribing wrote More Safety Data Would Be Nice, But We Need a Vaccine Now for Wired, November 11, 2020

The unequal scramble for coronavirus vaccines — by the numbers, a news report in Nature documenting wealthy countries’ pre-ordering of vaccines in development, August 24, 2020